Headlines

The NewsFuror
Showing posts with label Health/Science News. Show all posts
Showing posts with label Health/Science News. Show all posts

Tuesday, February 26, 2008

Anti-depressants 'of little use'

Anti-depressant tablets
Anti-depressant prescription rates have soared
New generation anti-depressants have little clinical benefit for most patients, research suggests.

A University of Hull team concluded that the drugs helped only a small group of the most severely depressed.

Marjorie Wallace, head of the mental health charity Sane, said that if these results were confirmed they could be "very disturbing".

But the makers of Prozac and Seroxat, two of the commonest anti-depressants, said they disagreed with the findings.

A spokesman for GlaxoSmithKline, which makes Seroxat, said the study only looked at a "small subset of the total data available".

Reviewed data

And Eli Lilly, which makes Prozac, said that "extensive scientific and medical experience has demonstrated it is an effective anti-depressant".

Patients are advised not to stop taking their medication without first consulting a doctor.

In total, the Hull team, who published their findings in the journal PLoS Medicine, reviewed data on 47 clinical trials.

They reviewed published clinical trial data, and unpublished data secured under Freedom of Information legislation.

They focused on drugs in the class known as Selective Serotonin Reuptake Inhibitors (SSRIs), which work by increasing levels of the mood controlling chemical serotonin in the brain.

These included fluoxetine (Prozac), venlafaxine (Efexor) and paroxetine (Seroxat) - all commonly prescribed in the UK.

There seems little reason to prescribe anti-depressant medication to any but the most severely depressed patients
Professor Irving Kirsch
University of Hull

The number of prescriptions for anti-depressants hit a record high in England in 2006 - even though official guidance stresses they should not be a first line treatment for mild depression.

The researchers found that even the positive effects seen on severely depressed patients were relatively small, and open to interpretation.

The seemingly good result came from the fact that these patients responded less to dummy pills (placebos) which they were given during trials, rather than any notable response to anti-depressants.

Lead researcher Professor Irving Kirsch said: "The difference in improvement between patients taking placebos and patients taking anti-depressants is not very great.

"This means that depressed people can improve without chemical treatments.

"Given these results, there seems little reason to prescribe anti-depressant medication to any but the most severely depressed patients, unless alternative treatments have failed to provide a benefit."

Professor Kirsch said the findings called into question the current system of reporting drug trials.

Revieweing guidance

Dr Tim Kendall, deputy director of the Royal College of Psychiatrists Research Unit, has published research concluding that drug companies tend only to publish research which shows their products in a good light.

He said the Hull findings undermined confidence in the ability to draw meaningful conclusions about the merit of drugs based on published data alone.

He called for drug companies to be forced to publish all their data.

The National Institute for Health and Clinical Excellence (NICE) is currently reviewing its guidance on the use of antidepressants.

Marjorie Wallace of Sane commented: "If these results were upheld in further studies, they would be very disturbing.

"The newer anti-depressants were the great hope for the future.... These findings could remove what has been seen as a vital choice for thousands in treating what can be a life-threatening condition."

Monday, February 25, 2008

Computers 'spot Alzheimer's fast'

elderly woman
Alzheimer's can be difficult to diagnose
Computers can diagnose Alzheimer's disease faster and more accurately than experts, research suggests.

University College London researchers say their work may help ensure patients are diagnosed earlier, increasing the chances of effective treatment.

Their study, published in the journal Brain, found computers can identify brain damage caused by Alzheimer's with an accuracy as high as 96%.

At present a definitive diagnosis is usually only possible after death.

Alzheimer's is caused by the build up in the brain of plaques and tangles of brain tissue filaments, which causes tissue to start wasting away.

It is currently diagnosed using a combination of brain scans, blood tests and patient interviews, but distinguishing the disease from other forms of dementia is difficult, and time consuming, and the accuracy of diagnosis is only about 85%.

The new method works by teaching a standard computer the differences between brain scans from patients with proven Alzheimer's, and people with no signs of the disease.

The two conditions can be distinguished with a high degree of accuracy on a single clinical MRI scan.

Researcher Professor Richard Frackowiak said: "The advantage of using computers is that they prove cheaper, faster and more accurate than the current method of diagnosis.

"The new method makes an objective diagnosis without the need for human intervention.

"This will be particularly attractive for areas of the world where there is a shortage of trained clinicians and when a standardised reliable diagnosis is needed, for example in drug trials."

Speed important

Professor Frackowiak emphasised that as symptoms only emerge after a considerable amount of damage has already occurred in the brain it is important to make an accurate diagnosis early to improve the chances of effectively preventing further deterioration.

He said: "The next step is to see whether we can use the technique to reliably track progression of the disease in a patient.

"This could prove a powerful and non-invasive tool for screening the efficacy of new drug treatments speedily, without a need for large costly clinical trials."

Dr Susanne Sorensen, of the Alzheimer's Society, said: "Currently, MRI imaging is not routinely used in diagnosing the diseases causing dementia.

"This paper puts a strong case for the wider use of this technique."

Dr Sorensen said it was vital the National Dementia Strategy currently being produced by the government makes early diagnosis a high priority.

Rebecca Wood, of the Alzheimer's Research Trust, said: "This promising computer aided technique could act as a second opinion to increase the accuracy of a doctor?s diagnosis.

"However, this research is in the early stages and further analysis is required to understand the full benefits and accuracy of this technique and to see if it can be used to assess the effectiveness of new drugs."

It is estimated that over 700,000 people in the UK are currently living with dementia, of which Alzheimer's is the most common form.

Friday, December 14, 2007

Call for rethink in obesity fight

Obese family
Obesity rates are set to double
Obesity cannot be tackled by just encouraging healthier eating and more exercise, health experts say.

The experts, led by a London-based academic, say governments should adopt more sophisticated approaches.

Work conditions, food subsidies, town planning and advert restrictions are all key, the experts wrote in the British Medical Journal.

The UK's Association of Directors of Public Health said change was happening but further improvements were needed.

Latest statistics show that a quarter of adults are obese in the UK, but the percentage is predicted to rise to over 50% if current trends continue.

There has been a lack of co-ordination over this and the response has therefore been slow
Dr Tim Crayford, of the Association of Directors of Public Health

The findings mirror the conclusions of the recent government-backed Foresight report in the UK, which said societal issues were also to blame for rising obesity levels.

These experts, led by a University College London academic, agreed, saying tackling obesity was far more complex than just encouraging healthy eating and more exercise.

They said large supermarket chains had displaced small, family-run stores and encouraged bulk purchases, convenience foods and super-sized portions.

They also criticised the impact of food advertising which they said encouraged children in particular to desire foods "high in saturated fats, sugars and salt".

And they said urban planning and design could play a key role in encouraging people to walk around towns rather than rely on cars.

These factors were particularly important for people from deprived areas as they were often more constrained by such barriers, they said.

'Dynamic'

The authors pointed to the example set by Norway, which has used a combination of food subsidies, price manipulation and clear nutrition labelling to steer people away from unhealthy food.

UCL expert Sharon Friel said a "dynamic" response was needed that included joined-up action at global, national and local levels.

"Missing in most obesity prevention strategies is the recognition that obesity - and its unequal distribution - is the consequence of a complex system that is shaped by how society organises its affairs."

Dr Tim Crayford, president of the Association of Directors of Public Health, said it was well-known that obesity was caused by multi-factoral problems.

"There has been a lack of co-ordination over this and the response has therefore been slow."

And he added: "There are signs that is now changing, but we are battling against the desire in western societies for more affluence which means more cars and richer food."

Thursday, October 4, 2007

Chilli compound fires painkiller


A chemical from chilli peppers may be able to kill pain without affecting touch or movement.

This might in theory mean a woman in labour could have an epidural without losing the ability to move her legs, or the sensation of her baby being born.

Conventional local anaesthetics affect all nerve cells.

But the researchers Harvard team, writing in Nature, said that with capsaicin, the chilli chemical, they can target just pain receptors.

However, a UK expert said it might be difficult to inject it safely.


The Holy Grail in pain science is to eliminate pathologic pain without impairing thinking, alertness, coordination or other vital functions of the nervous system
Dr Story Landis
National Institute of Neurological Disorders and Stroke

Numbness is actually a side-effect of the pain-killing properties of local anaesthetics - caused when the drug blocks signals not only from the nerve endings which cause pain, but other nerve endings which simply detect the sensation of touch.

And when anaesthetic "blocks", are injected into the spine, they can interfere with other nerves, causing temporary paralysis - such as that felt in the lower limbs after an epidural injection.

Cell door

The Harvard team used a molecule - QX-314 - which interferes with nerve signals in the same way as any other conventional anaesthetic, but which is too big to get into any nerve cell on its own.

Capsaicin, which is the substance that makes chilli peppers taste "hot", has an unique property - it can open a channel in the cell wall of nerve cells big enough for QX-314 to get in.

However, it can only do this in the cell walls of pain receptor neurons, meaning that these are the only nerve cells affected by the anaesthetic.


The technique has not yet been tried on humans, and it is hard to see how capsaicin could be used in this situation
Dr Joan Hester
British Pain Society

In rats, an injection of QX-314 and capsaicin killed pain, and caused no other effects. And when injected near the nerve controlling the hind leg, there was no paralysis.

The researchers said that this had the potential to "profoundly change pain treatment" before and during the millions of operations carried out under local anaesthetic every year.

Dr Story Landis, the director of the National Institute of Neurological Disorders and Stroke in the US, said that patients in chronic pain might also benefit.

"The Holy Grail in pain science is to eliminate pathologic pain without impairing thinking, alertness, coordination or other vital functions of the nervous system.

"It holds the promise of major future breakthroughs for the millions of people who suffer with disabling pain."

Burning feeling

Dr Joan Hester, the president of the British Pain Society, said that while capsaicin had been used for many years to reduce skin sensitivity linked to chronic pain, it caused an unpleasant burning sensation that was too much for some patients.

This might be even more of a problem if the chemical was injected below the skin, she said.

"The technique has not yet been tried on humans, and it is hard to see how capsaicin could be used in this situation."

However, she said that the study broke new ground: "Selective block of pain nerve fibres without numbness or motor block would be of great benefit in local anaesthesia by injection, for example in epidural anaesthesia"